Permanent Pacemaker Implantation After Isolated Aortic Valve Replacement: Incidence, Indications, and Predictors

Size: px
Start display at page:

Download "Permanent Pacemaker Implantation After Isolated Aortic Valve Replacement: Incidence, Indications, and Predictors"

Transcription

1 Permanent Pacemaker Implantation After Isolated Aortic Valve Replacement: Incidence, Indications, and Predictors Sam Dawkins, MB BS, Alex R. Hobson, MB BS, Paul R. Kalra, MD, Augustine T. M. Tang, DM, FRCS Ed (C-Th), James L. Monro, FRCS, and Keith D. Dawkins, MD, FRCP Wessex Cardiac Unit, Southampton University Hospital, Southampton, United Kingdom Background. Conducting system defects are common in patients with aortic valve disease. Aortic valve replacement may result in further conduction abnormalities and necessitate permanent pacemaker implantation (PPM). We sought to identify the contemporary incidence and predictors for early postoperative PPM in patients undergoing isolated aortic valve replacement. Methods. Data were analyzed from 354 consecutive patients undergoing isolated aortic valve replacement at a referral cardiac unit during a 30-month period; data were unavailable on 4 patients and a further 8 had undergone preoperative PPM. Results for the remaining 342 patients (97%; mean age, years), of whom 212 were males, are presented. The major indications for aortic valve replacement were valvular stenosis (n 224), regurgitation (n 70), or infective endocarditis (n 25). Preoperative conducting system disease was present in 26% of patients. Results. In-hospital mortality was 1.8% (6 of 342 patients). Postoperatively 29 patients (8.5%) required early PPM, of which 26 were during the index admission. Patients with preoperative conducting system disease (16% versus 6%; p 0.004) and valvular regurgitation (16% versus 7%; p 0.01) were more likely to require PPM as opposed to those without. Preoperative conducting system disease was the only independent predictor of PPM (p < 0.01); the relative risk of PPM requirement in this group was 2.88 (95% confidence interval, 1.31 to 6.33). Conclusions. Permanent pacemaker implantation requirement after aortic valve replacement is a common occurrence, and should be discussed as part of the preoperative consent process. Preexisting conducting disease and preoperative aortic regurgitation were predictors of PPM requirement. (Ann Thorac Surg 2008;85:108 12) 2008 by The Society of Thoracic Surgeons Aortic valvular stenosis and regurgitation are associated with abnormalities of conduction, including higher degrees of atrioventricular (AV) block [1, 2]. Aortic valve replacement (AVR) can result in the development of further conduction abnormalities [3], which may be associated with an increased risk of sudden death [4]. Higher degrees of AV block, although often reversible, may also necessitate permanent pacemaker implantation (PPM) [5]. Studies conducted in the late 1970s suggested that early PPM was required in approximately 6% of patients undergoing isolated AVR [6]. Advances in cardiac surgical techniques and improved availability have resulted in surgery being offered to a wider range of patients. Elderly patients, an increasing proportion of the adult population, gain substantial benefits from cardiac surgery [7], and this has resulted in a significant change in the demographics of patients undergoing AVR. Caution is therefore required when extrapolating data from older case series. Accepted for publication Aug 13, Address correspondence to Dr Dawkins, Wessex Cardiac Unit, Southampton University Hospital, Southampton SO16 6YD, United Kingdom; keith@dawkins.org. The most recent series (reported in 2003) is a prospective cohort study performed in 276 patients (mean age, years) undergoing AVR in a single center [8]. Patients were included irrespective of whether the primary indication for surgery was severe aortic valve disease or the need for revascularization with concomitant aortic valve disease. Permanent pacemaker implantation was indicated in 3.2% of patients. Identifying patients at increased risk of developing conduction system abnormalities that are likely to require postoperative PPM would be of substantial clinical benefit, facilitating the planning of postoperative care. It also has important implications in the context of informed preoperative consent. The aim of the current study was to establish the contemporary incidence of early postoperative PPM requirement in patients undergoing isolated AVR. In addition, we sought to identify clinical criteria that might predict the need for early postoperative PPM. Patients and Methods Patients Data were analyzed from 354 consecutive patients undergoing isolated AVR at the Wessex Cardiac Unit (a referral 2008 by The Society of Thoracic Surgeons /08/$34.00 Published by Elsevier Inc doi: /j.athoracsur

2 Ann Thorac Surg DAWKINS ET AL 2008;85: PERMANENT PACEMAKER IMPLANTATION AFTER AVR Table 1. Characteristics of 342 Patients Undergoing Isolated Aortic Valve Replacement Characteristic All Patients (n 342) PPM Subset (n 29) No PPM (n 313) p Value (PPM vs. No PPM) Age (y) NS Sex (male) 212 (62%) 19 (65%) 193 (62%) NS Conduction abnormalities 89 (20%) 14 (48%) 75 (22%) Indications for AVR AS 224 (66%) 16 (55%) 208 (61%) NS AR 70 (20%) 11 (38%) 59 (17%) 0.01 Mixed 20 (6%) 0 (0%) 20 (6%) NS Endocarditis 25 (7%) 2 (7%) 23 (7%) NS Others 3 (1%) 0 (0%) 3 (1%) NS Elective/emergency 283/80 25/4 258/76 NS Bioprosthetic/mechanical 195/147 16/13 179/134 NS Prosthetic AV diameter (mm) Cross-clamp time (min) NS Bypass time (min) NS Lowest operative temperature ( C) NS 109 CARDIOVASCULAR AR aortic regurgitation; AS aortic stenosis; AV aortic valve; AVR aortic valve replacement; NS not significant; PPM permanent pacemaker. cardiac center) during a 30-month period from January 2000 to July Patients were identified from a customdesigned cardiac surgical database (based on FoxPro), which is maintained by a dedicated data clerk. Eight patients had undergone preoperative PPM, and data were not available in a further 4 patients. The remaining 342 patients (mean age, years [ standard deviation]) formed the study population; 212 (62%) were males. Baseline demographic details are shown in Table 1. The major indications for AVR were predominant valvular stenosis (n 224, 66%), predominant regurgitation (n 70, 20%), or infective endocarditis (n 25, 7%). The majority of surgical procedures were performed on an elective basis (90%), and only one was a redo. Comprehensive perioperative data were collected from the database and from surgical or anesthetic notes. One hundred ninety-five patients (57%) received bioprosthetic valves, of which four were stentless (three homograft, one Toronto stentless porcine valve). The standard approach for myocardial protection within the unit includes intermittent, cold, anterograde blood cardioplegia supplemented with topical cooling. The mean length of follow-up was days (range, 2 to 938 days). All patients underwent standard 12-lead resting electrocardiography before surgery. Analyses of the recordings were performed by one of two experienced cardiologists. Preoperative conducting system disease was defined by the presence of at least one of the following abnormalities: first-degree AV block (PR interval 200 milliseconds), left bundle-branch block, right bundlebranch block, or left anterior hemiblock (mean QRS axis, 30 degrees, or greater). Postoperatively, resting electrocardiographs were repeated and interpreted using the same criteria. The first electrocardiograph in the notes after day 1 was used. The requirement for PPM was determined by the attending cardiologist and was based on the general policy of waiting until at least the fifth postoperative day. Uniformly accepted indications within the department are the continued presence of complete heart block, symptomatic bradycardia, or the need to prevent undue bradycardia while controlling tachyarrhythmias at day 7. The actual decision and timing of PPM was, therefore, determined on an individual patient needs basis. All systems were implanted using a transvenous approach. Preoperative clinical characteristics thought likely to influence the conducting system and several operative variables were analyzed to determine whether any were predictive of postoperative PPM requirement. This audit was approved by the Southampton & South West Hampshire Research Ethics Committee. Statistical Analysis All results are presented as mean standard deviation. Data were analyzed using Stat View 4.5 (Abacus Concepts Inc, Berkeley, CA). Analysis of variance and 2 were used as appropriate. The receiver-operating characteristic curve for prosthetic aortic valve diameter was drawn (MedCalc 5.0, MedCalc Inc, Mariakerke, Belgium). The cutoff level that resulted in the highest product of sensitivity and specificity was considered the optimum for predicting PPM requirement. Logistic regression analysis was performed to determine independent predictors of PPM requirement. A probability value of less than 0.05 was considered significant. Results Preoperative Electrocardiographic Findings A preoperative resting electrocardiograph demonstrated that the majority of patients were in sinus rhythm (n 300, 88%); atrial fibrillation was present in 40 patients (12%) and complete AV block in a further 2. Other

3 110 DAWKINS ET AL Ann Thorac Surg PERMANENT PACEMAKER IMPLANTATION AFTER AVR 2008;85: Table 2. Preoperative Electrocardiographic Findings in 342 Patients Undergoing Isolated Aortic Valve Replacement a Rhythm Number of Patients (Total n 342) Sinus rhythm 300 (88%) Atrial fibrillation 40 (12%) CHB 2 (1%) Conducting abnormalities LAHB 34 (10%) 1st-degree AV block 23 (7%) LBBB 23 (7%) RBBB 17 (5%) a Five patients had more than one conducting system abnormality. AV atrioventricular; CHB complete atrioventricular block; LAHB left anterior hemiblock (mean QRS axis 30 degree); LBBB left bundle-branch block; RBBB right bundle-branch block. conducting system abnormalities were present in 89 patients (26%; Table 2). Postoperatively, 29 patients (8.5%) required a permanent pacemaker (PPM). Of these, 23 patients received DDD and 6 patients received VVI pacemakers at the discretion of the attending cardiologist. The indications for PPM were persistent complete AV block (n 25), sinus bradycardia (n 3), and atrial fibrillation (required to prevent bradycardia while controlling faster rates, n 1). After surgery, the mean time to PPM implantation was 13 days (range, 6 to 57 days). Twenty-six patients (90%) received PPM during the index admission, a mean duration of 11 days after aortic valve surgery (range, 6 to 25 days). Predictors of Permanent Pacemaker Implantation Requirement Patients with aortic regurgitation as an indication for surgery were more likely to require PPM than those with other indications (16% versus 7%; p 0.01; Table 1). The size of the aortic valve prosthesis was associated with PPM requirement; receiver-operating characteristic analysis demonstrated that the best cutoff prosthetic aortic valve diameter for separating patients according to PPM requirement was 24 mm (area under curve 0.60; 95% confidence interval, 0.55 to 0.65). At this point sensitivity was 53% and specificity 68%. A cutoff value of 23 mm gave a sensitivity of 80% with a low specificity of 32%. Patients with aortic regurgitation received larger prosthetic valves ( mm) as compared with the rest of the study group ( mm; p ). More patients with electrocardiographic evidence of preoperative conducting system disease needed PPM as compared with those with normal conduction (16% versus 6%; p 0.004). No difference was seen when each abnormality of conduction was considered alone, although individual numbers were small. The following variables were not associated with an increased requirement for permanent pacemaker: age, sex, aortic stenosis or endocarditis as indication for surgery, elective or emergency procedure, valve type (mechanical or bioprosthetic), lowest operative temperature, and total cross-clamp or bypass time. Logistic regression analysis demonstrated that the presence of preoperative conducting system disease was the only independent predictor of requirement for postoperative PPM (p ). In the presence of preoperative conducting system disease, the relative risk of PPM requirement was 2.88 (95% confidence interval, 1.31 to 6.33). Comment We have shown that PPM is a common requirement after isolated AVR in a contemporary population (50% older than 70 years); approximately 1 in every 12 patients undergoing this procedure will require early PPM. The vast majority (90%) of these occurred during the index admission with potential adverse impact on hospitalization times. Histologic abnormalities of the conducting system are common in patients with aortic valve disease, and suggestions regarding their cause have varied from mechanical (elevated left ventricular pressures) and ischemic factors, to exaggerated age-related change and primary degenerative disease of the conducting system [9, 10]. Aortic valve disease, and aortic regurgitation in particular, results in fibrous thickening of the endocardium of the ventricular septum [9]. Subsequent impingement on underlying conducting tissue is plausible and may explain our finding that aortic regurgitation was associated with PPM. Follath and Ginks [3] demonstrated that intraventricular conduction defects were common after aortic valve surgery (26%). The intimate relationship between the aortic valve and conducting tissue has led to the suggestion that direct trauma at the time of surgery might be involved, occurring as a consequence of injury from sutures, pressure from residual calcific material, or impingement of the prosthetic valvular seat on conducting tissue [9]. Indeed continuous sutures rather than interrupted sutures have been shown to increase the incidence of postoperative AV conduction abnormalities and PPM [11]. The development of conduction defects after cardiac surgery may also be associated with total bypass and cross-clamp time, degree of myocardial cooling [12, 13], and method of cardioplegia [14]. These presumably reflect severity of ischemic damage to the conducting system. In our study these factors did not impact on postoperative PPM requirement, which may be related, at least in part, to advances in myocardial preservation during cardiopulmonary bypass. Nair and colleagues [15] showed that in the presence of calcific aortic stenosis, mitral annular calcification was associated with a greater need for PPM after valve replacement. Although in the current study we did not calculate an index of valvular calcification, aortic regurgitation and not stenosis was associated with PPM. Patients with aortic regurgitation received larger valve prostheses than patients with other defects. Although it is possible that larger prostheses were associated with greater operative

4 Ann Thorac Surg DAWKINS ET AL 2008;85: PERMANENT PACEMAKER IMPLANTATION AFTER AVR Table 3. Summary of Previous Studies Investigating the Incidence of Permanent Pacemaker After Valvular Surgery Author Date Reported Number Studied Isolated AVR Comments Incidence of PPM Keefe et al [6] Yes Isolated AVR 6% Jaeger et al [18] No Repeat valvular surgery 7.9% Del Rizzo et al [16] ,448 No Open heart surgery 1.3% Morell et al [20] No AVR CABG in the elderly 6.5% Lewis et al [17] No Reoperative cardiac surgery 9.7% Kolh et al [19] No AVR CABG in the elderly 6% Limongelli et al [8] No AVR CABG 3.2% 111 CARDIOVASCULAR AVR aortic valve replacement; CABG coronary artery bypass grafting; PPM permanent pacemaker. trauma, a larger aortic root may also be indicative of more severe valvular disease and hence preoperative exposure to more unfavorable mechanical effects on the conducting system. Whether this renders the conducting system susceptible to ischemic damage during cardiac surgery is uncertain. In this study a conduction abnormality identified on a preoperative electrocardiograph was the only independent predictor of PPM; it is likely that such patients are more vulnerable to the adverse effects of surgery. From the current sample size it was not possible to identify a specific conduction abnormality that presented the greatest risk. Few previous studies have evaluated the incidence of PPM after valvular surgery. A summary is shown in Table 3. Keefe and coworkers [6] evaluated 102 consecutive patients undergoing isolated AVR at a single institution during 1977 to Postoperative complete heart block was common, occurring in 18 patients (18%). In the majority of cases this was a transient phenomenon. Six patients (6%) required PPM before discharge, and a further 3 patients (3%) required late PPM (median follow-up, 4.2 years; time of late PPM not specified). The investigators were unable to demonstrate any predictive clinical or operative variables for the early development of postoperative complete AV block. Del Rizzo and associates [16] evaluated all patients undergoing open heart surgery at their center during a 5.5-year period. Of the 3,448 patients included, 1.3% required PPM. Multivariate logistic regression analysis showed that aortic valve surgery (odds ratio, 8.23; p 0.001), the absence of preoperative sinus rhythm (odds ratio, 5.60; p 0.001); postoperative myocardial infarction (odds ratio, 3.46; p 0.024), and female sex (odds ratio, 2.52; p 0.003) were independent predictors of PPM. Aortic valve surgery in this study included combined procedures; data pertaining to the incidence of PPM in isolated AVR were not reported. Intuitively more complex cardiac surgery will be more likely to adversely affect the conducting system; indeed, the need for PPM is increased after reoperative cardiac surgery (9.7%) [17]. In this clinical setting several factors were found to strongly relate to increased need: valve replacement (including AVR), preoperative endocarditis, number of reoperations, age, and degree of hypothermia during bypass. Increased total aortic cross-clamp and bypass times were also associated with PPM. A further study showed that in patients surviving repeat valvular surgery, 7.9% required PPM [18]. Some studies have looked specifically at AVR in the elderly. Kolh and associates [19] studied 83 octogenarians undergoing AVR between 1992 and 1997 (with coexistent coronary artery bypass graft surgery in 25%) and showed that PPM was required in 5 patients (6%). Morell and colleagues [20] studied a group of 46 elderly patients (range, 75 to 88 years) undergoing AVR (and coronary artery bypass graft surgery in 57%). In this group, 6.5% required PPM insertion. In a more recent cohort study of 276 patients undergoing AVR [8], 3.2% required PPM. Multivariate logistic regression analysis identified preoperative aortic regurgitation, myocardial infarction, pulmonary hypertension, and postoperative electrolyte imbalance as predictors of postoperative PPM requirement. This group was on average 10 years younger than in our study and also included patients undergoing additional interventions such as coronary artery bypass grafting. In patients in whom the primary indication was the requirement for revascularization, it is likely that the associated aortic valve disease was less severe. In addition, patients with preoperative atrial fibrillation were excluded in this study. These important differences are likely to explain the comparatively low requirement for PPM in this study. In common with the present study, aortic regurgitation was found to predict the requirement for PPM. In this study the vast majority (90%) of implants occurred during the index surgical admission, and it is likely that this contributes to protracted hospitalization (mean time to implant after surgery, 11 days). Habicht and coworkers [21] looked at the incidence of late conduction system abnormalities after AVR in 100 consecutive cases. They reported that 13.7% of operative survivors with normal perioperative electrocardiographs exhibited late conduction disorders. These occurred from 3 to 102 months after surgery. Only 1 patient in this study required PPM 82 months after AVR. Whether this can be directly attributed to AVR is debatable. In our study 3 patients received PPM during our follow-up period ( days) after initial hospital discharge (the latest, 57 days after AVR). Our study was primarily designed to investigate early PPM requirement (especially on the index admission). It is a limitation of this study that we do not have more comprehensive follow-up data, which

5 112 DAWKINS ET AL Ann Thorac Surg PERMANENT PACEMAKER IMPLANTATION AFTER AVR 2008;85: may have identified additional patients who required late PPM implantation. Previous studies have shown that in patients receiving PPM after AVR, the requirement for PPM persists. Sniezek and associates [22] studied 22 patients receiving PPM after AVR. In 1 patient the indication for PPM (complete heart block) disappeared 24 months after AVR. In all other patients the requirement for PPM persisted for the duration of follow-up (range, 9 to 196 months). It therefore appears that the vast majority of PPM are implanted during the index admission and that the indication for PPM requirement again persists in the majority. Contemporary surgical techniques have resulted in a gratifyingly low in-hospital mortality of 1.8% for this large consecutive series of patients undergoing isolated AVR. Nevertheless, the requirement for early PPM implantation after isolated AVR is common. Although the majority of patients are likely to accept pacing as an additional intervention, this should be fully discussed preoperatively as part of the informed consent process. No single variable appears to reliably identify all patients who will require a postoperative PPM. Although careful monitoring should be performed on all patients, particular attention should be paid to patients with preexisting conducting system disease and those undergoing surgery for aortic regurgitation, particularly after the insertion of large valve prosthesis, because they appear to be at greater risk. References 1. Alblaza SG, Blanco G, Maranhao V, et al. Calcific aortic valvular disease associated with complete heart block. Case reports of successful correction. Dis Chest 1968;54: Jensen B, Sigurd B. Atrioventricular block in aortic insufficiency. Mechanism, ECG features and clinical consequences. Acta Med Scand 1972;192: Follath F, Ginks WR. Changes in the QRS complex after aortic valve replacement. B Heart J 1972;34: Thomas JL, Dickstein RA, Parker FB Jr, et al. Prognostic significance of the development of left bundle conduction defects following aortic valve replacement. J Thorac Cardiovasc Surg 1982;84: Gannon PG, Sellers RD, Kanjuhm VI, Edwards JE, Lillehei CW. Complete heart block following replacement of the aortic valve. Circulation 1966;33(Suppl 1):I Keefe DL, Griffin JC, Harrison DC, Stinson EB. Atrioventricular conduction abnormalities in patients undergoing isolated aortic or mitral valve replacement. Pacing Clin Electrophysiol 1985;8: Dalrymple-Hay MJ, Alzetani A, Aboel-Nazar S, Haw M, Livesey S, Monro J. Cardiac surgery in the elderly. Eur J Cardiothorac Surg 1999;15: Limongelli G, Ducceschi V, D Andrea A, et al. Risk factors for pacemaker implantation following aortic valve replacement: a single center experience. Heart 2003;89: Fukuda T, Hawley RL, Edwards JE. Lesions of conduction tissue complicating aortic valvular replacement. Chest 1976; 69: Davies M, Harris A. Pathological basis of primary heart block. Br Heart J 1969;31: Totaro P, Calamai G, Montesi G, Barzaghi C, Vaccari M. Continuous suture technique and impairment of the atrioventricular conduction after aortic valve replacement. J Card Surg 2000;15: Baerman JM, Kirsh MM, de Buitleir M, et al. Natural history and determinants of conduction defects following coronary artery bypass surgery. Ann Thorac Surg 1987;44: Caretta Q, Mercanti CA, De Nardo D, et al. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. Eur Heart J 1991; 12: Flack JE 3rd, Hafer J, Engelman RM, Rousou JA, Deaton DW, Pekow P. Effect of normothermic blood cardioplegia on postoperative conduction abnormalities and supraventricular arrhythmias. Circulation 1992;86(5 Suppl):II Nair CK, Sketch MH, Ahmed I, et al. Calcific valvular aortic stenosis with and without mitral annular calcium. Am J Cardiol 1987;60: Del Rizzo DF, Nishimura S, Lau C, Sever J, Goldman BS. Cardiac pacing following surgery for acquired heart disease. J Card Surg 1996;11: Lewis JW Jr, Webb CR, Pickard SD, Lehman J, Jacobsen G. The increased need for a permanent pacemaker after reoperative cardiac surgery. J Thorac Cardiovasc Surg 1998;116: Jaeger FJ, Trohman RG, Brener S, Loop F. Permanent pacing following repeat cardiac valve surgery. Am J Cardiol 1994; 74: Kolh P, Lahaye L, Gerard P, Limet R. Aortic valve replacement in the octogenarians: perioperative outcome and clinical follow-up. Eur J Cardiothorac Surg 1999;16: Morell V, Daggett W, Pezzella A, Moran J, Bitran D. Aortic stenosis in the elderly: result of aortic valve replacement. J Cardiovasc Surg (Torino) 1996;37: Habicht J, Scherr P, Zerkowski H, Hoffmann A. Late conduction defects following aortic valve replacement. J Heart Valve Dis 2000;9: Sniezek M, Malecka B, Bednarek J, et al. Patients history following artificial aortic valve and pacemaker implantation. Przegl Lek 2004;61:

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger

More information

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,

More information

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Original Article Predictors and Frequency of Conduction Disturbances After Open-Heart Surgery

Original Article Predictors and Frequency of Conduction Disturbances After Open-Heart Surgery www.ipej.org 14 Original Article Predictors and Frequency of Conduction Disturbances After Open-Heart Surgery Zahra Emkanjoo, MD 1, Mansour Mirza-Ali, MD 2, Abollfath Alizadeh MD 1, Saied Hosseini MD 3,

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative

More information

Pacemaker dependency after isolated aortic valve replacement: do conductance disorders recover over time?

Pacemaker dependency after isolated aortic valve replacement: do conductance disorders recover over time? Interactive CardioVascular and Thoracic Surgery 16 (2013) 476 481 doi:10.1093/icvts/ivs555 Advance Access publication 8 January 2013 ORIGINAL ARTICLE - ADULT CARDIAC Pacemaker dependency after isolated

More information

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences Rates of and predictors for the need of permanent pacemaker and its long-term utilization in patients undergoing surgical or transcatheter aortic valve replacement Hafþór Ingi Ragnarsson Thesis for the

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Simultaneous Aortic and Mitral Valve Replacement in Octogenarians: A Viable Option?

Simultaneous Aortic and Mitral Valve Replacement in Octogenarians: A Viable Option? Simultaneous Aortic and Mitral Valve Replacement in Octogenarians: A Viable Option? Ariane Maleszka, MD,* Georg Kleikamp, MD, PhD,* Armin Zittermann, PhD, Maria R. G. Serrano, MD, and Reiner Koerfer, MD,

More information

Outcome of elderly patients with severe but asymptomatic aortic stenosis

Outcome of elderly patients with severe but asymptomatic aortic stenosis Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Emergency Intraoperative Echocardiography

Emergency Intraoperative Echocardiography Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will

More information

Abnormalities Caused by Left Bundle Branch Block

Abnormalities Caused by Left Bundle Branch Block Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Physician Assistant Studies, Department 12-17-2010 Abnormalities Caused by Left Bundle Branch

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

The increase in the lifespan of the western population

The increase in the lifespan of the western population Outcome After Aortic Valve Replacement in Octogenarians Bruno Chiappini, MD, Nicola Camurri, MD, Antonio Loforte, MD, Luca Di Marco, MD, Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD Department

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT

THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT Gideon Cohen, MD Tirone E. David, MD Joan Ivanov, MSc Sue Armstrong, MSc

More information

Experience with 500 Stentless Aortic Valve Replacements

Experience with 500 Stentless Aortic Valve Replacements Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest

More information

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic

More information

Surgical Treatment for Atrioventricular Septal Defect. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery

Surgical Treatment for Atrioventricular Septal Defect. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery Surgical Treatment for Atrioventricular Septal Defect Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery 1 History Rastelli classification (Rastelli) Pulmonary artery banding (Muller & Dammann)

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Management of Difficult Aortic Root, Old and New solutions

Management of Difficult Aortic Root, Old and New solutions Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult

More information

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim 42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of

More information

Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve

Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 3, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.04.007 Early and

More information

Is it worth placing ventricular pacing wires in all patients postcoronary artery bypass grafting?

Is it worth placing ventricular pacing wires in all patients postcoronary artery bypass grafting? Interactive CardioVascular and Thoracic Surgery 15 (2012) 489 493 doi:10.1093/icvts/ivs125 Advance Access publication 22 May 2012 - ADULT CARDIAC Is it worth placing ventricular pacing wires in all patients

More information

Decellularization of Aortic Homografts: South American and European Current Experience

Decellularization of Aortic Homografts: South American and European Current Experience Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Debate in CHD - When Should We

Debate in CHD - When Should We Debate in CHD - When Should We Replace Pulmonary Valve? Lee, Jae Young Dept. of Pediatrics, Seoul Saint Mary s Hospital The Catholic University of Korea 14 yr/m, TOF repair (1yr) FC I PR Fraction - 48

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III)

Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III) Journal of Rare Cardiovascular Diseases 2017; 3 (3): 81 85 www.jrcd.eu ORIGINAL PAPER Diseases of the heart Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III) Justyna

More information

12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP

12-Lead ECG Interpretation. Kathy Kuznar, RN, ANP 12-Lead ECG Interpretation Kathy Kuznar, RN, ANP The 12-Lead ECG Objectives Identify the normal morphology and features of the 12- lead ECG. Perform systematic analysis of the 12-lead ECG. Recognize abnormalities

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients

The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients The Turkish Journal of Pediatrics 2008; 50: 549-553 Original The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients Selman Vefa Yıldırım 1, Kürşad

More information

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of

More information

Electrocardiography Abnormalities (Arrhythmias) 7. Faisal I. Mohammed, MD, PhD

Electrocardiography Abnormalities (Arrhythmias) 7. Faisal I. Mohammed, MD, PhD Electrocardiography Abnormalities (Arrhythmias) 7 Faisal I. Mohammed, MD, PhD 1 Causes of Cardiac Arrythmias Abnormal rhythmicity of the pacemaker Shift of pacemaker from sinus node Blocks at different

More information

P have been used for mitral and aortic valve replacement

P have been used for mitral and aortic valve replacement A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,

More information

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient

More information

Although most patients with Ebstein s anomaly live

Although most patients with Ebstein s anomaly live Management of Neonatal Ebstein s Anomaly Christopher J. Knott-Craig, MD, FACS Although most patients with Ebstein s anomaly live through infancy, those who present clinically as neonates are a distinct

More information

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8)

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Page 1 of 12 Centers for Medicare & Medicaid Services National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Tracking Information Publication Number 100-3 Manual Section Number 20.8 Manual

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin. Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong

Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin. Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong Classification (by Kirklin) I. Subarterial (10%) Outlet, conal, supracristal,

More information

Mitral Valve Surgery: Lessons from New York State

Mitral Valve Surgery: Lessons from New York State Mitral Valve Surgery: Lessons from New York State Joanna Chikwe, MD Professor of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai Chairman & Program Director Department of Cardiovascular

More information

Appendix D Output Code and Interpretation of Analysis

Appendix D Output Code and Interpretation of Analysis Appendix D Output Code and Interpretation of Analysis 8 Arrhythmia Code No. Description 8002 Marked rhythm irregularity 8110 Sinus rhythm 8102 Sinus arrhythmia 8108 Marked sinus arrhythmia 8120 Sinus tachycardia

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Reconstruction of the intervalvular fibrous body during aortic and

Reconstruction of the intervalvular fibrous body during aortic and Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

The Role Of Decellularized Valve Prostheses In The Young Patient

The Role Of Decellularized Valve Prostheses In The Young Patient The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

The strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?

The strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery? Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?* Nirupama G. Talwalkar, MD, FCCP; Gerald M. Lawrie, MD, FCCP; Nan Earle, BS; and Michael E. DeBakey, MD, FCCP Background:

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

The risk-benefit ratio of mitral valve operation is

The risk-benefit ratio of mitral valve operation is Degenerative Mitral Regurgitation: When Should We Operate? Malcolm J. R. Dalrymple-Hay, PhD, Mark Bryant, Richard A. Jones, MRCP, Stephen M. Langley, FRCS, Steven A. Livesey, FRCS, and James L. Monro,

More information

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Thank you for taking the time to review the draft Cardiovascular Diseases and Disorders chapter. Please provide

More information

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute

More information

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for

More information

Atrial fibrillation (AF) is associated with increased morbidity

Atrial fibrillation (AF) is associated with increased morbidity Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery

More information

Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up

Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: A Hancock I Vekus Edwards at 4- to 7-Years Follow-up Francisco Nistal, M.D., Edurne Artifiano, M.D., and Ignacio Gallo,

More information

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing The Journal of Innovations in Cardiac Rhythm Management, 3 (2012), 976 981 HEART FAILURE RESEARCH ARTICLE Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Femoral Versus Aortic Cannulation for Surgery of Chronic Ascending Aortic Aneurysm

Femoral Versus Aortic Cannulation for Surgery of Chronic Ascending Aortic Aneurysm Femoral Versus Aortic Cannulation for Surgery of Chronic Ascending Aortic Aneurysm Fitsum Lakew, MD, Piotr Pasek, MD, Michael Zacher, MD, Anno Diegeler, MD, and Paul P. Urbanski, MD Department of Cardiovascular

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Bhakta N, Liu Q, Yeo F, et al. Cumulative burden

More information

PPM: How to fit a big valve in a small heart

PPM: How to fit a big valve in a small heart PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat

More information

Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study

Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study Open Access To cite: Girerd N, Magne J, Pibarot P, et al. Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study.

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional

More information

Gender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences

Gender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences Gender Differences in Valvular Heart Disease Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences Obstacles Interest in gender differences is a relatively new phenomenon Registries/RCT

More information

Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y.

Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y. UvA-DARE (Digital Academic Repository) Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y. Link to publication Citation for published version (APA): Yong, Z. Y. (2012).

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

How to Avoid Prosthesis-Patient Mismatch

How to Avoid Prosthesis-Patient Mismatch How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

More information

Spotlight on Valvular Heart Disease Guidelines

Spotlight on Valvular Heart Disease Guidelines Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017

More information

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole La strategia diagnostica: il monitoraggio ecg prolungato Michele Brignole ECG monitoring and syncope In-hospital monitoring Holter Monitoring External loop recorder Remote (at home) telemetry Implantable

More information

ery: Comparison of Predicted and Observed Resu ts

ery: Comparison of Predicted and Observed Resu ts Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,

More information

The first report of the Society of Thoracic Surgeons

The first report of the Society of Thoracic Surgeons REPORT The Society of Thoracic Surgeons National Congenital Heart Surgery Database Report: Analysis of the First Harvest (1994 1997) Constantine Mavroudis, MD, Melanie Gevitz, BA, W. Steves Ring, MD, Charles

More information

Indications and Late Results of Aortic Valve Repair

Indications and Late Results of Aortic Valve Repair Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the

More information

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

T he treadmill exercise test is the classic initial investigation

T he treadmill exercise test is the classic initial investigation 1416 CARDIOVASCULAR MEDICINE Improving the positive predictive value of exercise testing in women Y K Wong, S Dawkins, R Grimes, F Smith, K D Dawkins, I A Simpson... See end of article for authors affiliations...

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information